National Cancer Data Base report on osteosarcoma of the head and neck
Open Access
- 4 September 2003
- Vol. 98 (8) , 1670-1680
- https://doi.org/10.1002/cncr.11716
Abstract
BACKGROUND Osteosarcoma is the most common primary bone malignancy overall but is encountered infrequently in the head and neck. Limited data are available on the significance of prognostics factors and results of therapy for patients with head and neck osteosarcoma (HNOS). It is known that surgical therapy is critical to successful outcome. The impact of adjuvant chemotherapy has not been defined well. METHODS The National Cancer Data Base has collected data on cases of HNOS by voluntary accrual from participating hospitals. This database was used to assess patient demographics, tumor characteristics, treatment, and outcome for an 11-year period extending from 1985 to 1996. RESULTS The data set contained 496 cases of HNOS. Overall, the 5-year disease-specific survival rate was 59.7%. Factors associated with a poor prognosis were age older than 60 years; nonmandibular tumor location; tumor size > 6 cm; histologic type of osteoblastic, not otherwise specified (NOS); advanced disease stage; nonsurgical initial therapy; and positive margins of resection. Increased use of multimodality therapy was noted during the later years of the study. No substantial difference in the 5-year survival rate was noted between treatment with surgery alone (74.7%) and surgery with adjuvant chemotherapy (71.3%), despite the greater prevalence of tumors with poor prognostic factors in the surgery and adjuvant chemotherapy group. CONCLUSIONS Surgery with clear margins is an important factor in successful therapy for patients with HNOS. Improved survival has been noted within the last 2 decades compared with historic controls. Multiple negative prognostic factors have been identified and should be considered in treatment planning. The role of chemotherapy has not been defined well, but its incorporation into treatment of patients with high-risk tumors may improve survival. Cancer 2003. © 2003 American Cancer Society. DOI 10.1002/cncr.11716Keywords
This publication has 19 references indexed in Scilit:
- Craniofacial osseous and chondromatous sarcomas in British Columbia—a review of 34 casesOral Oncology, 2000
- Nonmetastatic Osteosarcoma of the Extremity: Results of a Neoadjuvant Chemotherapy Protocol (IOR/OS-3) with High-dose Methotrexate, Intraarterial or Intravenous Cisplatin, Doxorubicin, and Salvage Chemotherapy Based on Histologic Tumor ResponseTumori Journal, 1999
- Osteosarcoma of the head and neck: A review of the johns hopkins experienceThe Laryngoscope, 1999
- The National Cancer Data Base Report on Cancer of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1998
- Osteosarcoma of the Head and Neck: Meta‐analysis of Nonrandomized StudiesThe Laryngoscope, 1997
- The National Cancer Data Base report on patterns of hospital reportingCancer, 1996
- Radical surgical treatment in craniofacial osteosarcoma gives excellent survival. A retrospective cohort study of 14 patientsOral Oncology, 1994
- Osteogenic Sarcoma of the Head and Neck: The UCLA ExperienceJAMA Otolaryngology–Head & Neck Surgery, 1991
- Chemotherapy of OsteosarcomaPublished by Wolters Kluwer Health ,1975
- Osteogenic sarcoma of the facial and cranial bones: A review of forty-three casesThe American Journal of Surgery, 1971